UNITED THERAPEUTICS Corp SEC filings UTHR

UNITED THERAPEUTICS Corp has 1,002 filings in SEC EDGAR's recent list, going back to Apr 20, 2023. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

UNITED THERAPEUTICS Corp SEC filings
Form Description Filed Period
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 POS Filing Jul 13, 2026 —
S-8 Employee stock plan registration Jul 13, 2026 —
S-8 Employee stock plan registration Jul 30, 2025 —
S-8 Employee stock plan registration Jul 31, 2024 —
S-8 Employee stock plan registration Aug 2, 2023 —

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
UTHR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Silver Spring, MD
SEC filer status
Large accelerated filer
SEC CIK
1082554

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.